CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
-7.95%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$252M
AUM Growth
+$252M
(-23%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
81.4%
Holding
29
New
4
Increased
8
Reduced
8
Closed
3
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$13.2M |
| 2 |
Mineralys Therapeutics
MLYS
|
$5.41M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$4.66M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$4.63M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$3.42M |
Top Sells
| 1 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$46.9M |
| 2 |
Disc Medicine
IRON
|
$4.7M |
| 3 |
SLRN
ACELYRIN
SLRN
|
$4.08M |
| 4 |
Direxion Daily S&P Biotech Bear 3X Shares
LABD
|
$2.06M |
| 5 |
Pliant Therapeutics
PLRX
|
$1.78M |
Sector Composition
| 1 | Healthcare | 98.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pliant Therapeutics
PLRX
$101M
| $52.3M | 20.72% | 3,014,199 -102,818 | -3% | -$1.78M |
|
2
Repare Therapeutics
RPTX
$71.7M
| $35.8M | 14.2% | 2,966,674 -32,060 | -1% | -$387K |
|
3
Cullinan Oncology
CGEM
$445M
| $30.9M | 12.25% | 3,414,189 | – | – |
|
|
SLRN
4
DELISTED
ACELYRIN
SLRN
| $23M | 9.12% | 2,262,990 -400,816 | -15% | -$4.08M |
|
|
ORTX
5
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $14M | 5.56% | 12,315,654 +11,559,916 | +1,530% | +$13.2M |
|
6
Larimar Therapeutics
LRMR
$310M
| $13.5M | 5.35% | 3,414,468 | – | – |
|
7
Keros Therapeutics
KROS
$618M
| $13M | 5.15% | 407,633 +5,515 | +1% | +$176K |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $9.44M | 3.74% | 2,180,934 +58,894 | +3% | +$255K |
|
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $7.66M | 3.04% | 215,000 +130,000 | +153% | +$4.63M |
|
10
Compass Therapeutics
CMPX
$483M
| $5.57M | 2.21% | 2,829,712 | – | – |
|
|
11
Mineralys Therapeutics
MLYS
$1.03B
| $5.41M | 2.14% | +568,379 | New | +$5.41M |
|
|
INZY
12
DELISTED
Inozyme Pharma
INZY
| $5.33M | 2.11% | 1,270,027 +75,000 | +6% | +$315K |
|
|
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.12M | 2.03% | 1,299,359 +531,914 | +69% | +$2.1M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $4.66M | 1.85% | +92,888 | New | +$4.66M |
|
|
15
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
| $4.64M | 1.84% | 225,000 -100,000 | -31% | -$2.06M |
|
|
TSVT
16
DELISTED
2seventy bio
TSVT
| $3.93M | 1.56% | 1,002,007 +150,000 | +18% | +$588K |
|
|
17
MoonLake Immunotherapeutics
MLTX
$3.54B
| $3.42M | 1.36% | +60,000 | New | +$3.42M |
|
18
Ovid Therapeutics
OVID
$91M
| $3.32M | 1.32% | 864,822 | – | – |
|
19
Sagimet Biosciences
SGMT
$244M
| $3.07M | 1.22% | +348,842 | New | +$3.07M |
|
|
OMGA
20
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.27M | 0.9% | 1,055,882 | – | – |
|
21
Black Diamond Therapeutics
BDTX
$157M
| $2.07M | 0.82% | 720,000 -30,000 | -4% | -$86.1K |
|
22
Rallybio
RLYB
$22.4M
| $1.32M | 0.52% | 390,734 -152,040 | -28% | -$512K |
|
|
23
Disc Medicine
IRON
$2.07B
| $1.17M | 0.47% | 25,000 -100,139 | -80% | -$4.7M |
|
|
LENZ
24
LENZ Therapeutics
LENZ
$1.1B
| $573K | 0.23% | 230,938 | – | – |
|
|
FRLN
25
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $373K | 0.15% | 86,654 +64,988 | +300% | +$279K |
|